MFDS — authorised 13 June 2022
- Marketing authorisation holder: ALNYLAM PHARMS INC
- Status: likely_approved
🇰🇷 Amvuttra in South Korea
MFDS authorised Amvuttra on 13 June 2022
Marketing authorisation
Amvuttra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Amvuttra approved in South Korea?
Yes. MFDS authorised it on 13 June 2022.
Who is the marketing authorisation holder for Amvuttra in South Korea?
ALNYLAM PHARMS INC holds the South Korean marketing authorisation.